SEC Filings

All SEC Filings

Annual Reports

Quarterly Reports

Section 16 Filings

Latest Filing

Current Report

Latest Proxy Statement

All SEC Filings

news

June 27
Adial Pharmaceuticals Announces Database Lock for the ONWARD™ Phase 3 Clinical Trial
Continue Reading
June 14
Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company’s Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence
Continue Reading
May 19
Adial Pharmaceuticals Announces Research Collaboration with the Medical College of Wisconsin to Advance Purnovate’s Adenosine Compounds as Potential Treatments for Diabetes and NASH
Continue Reading
May 16
Adial Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
Continue Reading
May 4
Adial Pharmaceuticals Announces Research Collaboration with UC San Diego to Advance Purnovate’s Adenosine Compounds as Potential Treatments for Inflammatory Diseases & Disorders
Continue Reading

Tweets by AdialPharma

Adial Overview 2020
Watch Now
Adial Overview
Watch Now
About the growing AUD market and Adial's targeted potential treatment
Watch Now
NBC29: UVA Researchers & Adial looking into using Purnovate in Burn Wound Care
Watch Now
CEO Bill Stilley talks about AD04 on CBS46 Atlanta
Watch Now
Newsy Morning Rush with Bill Stilley discussing AUD & AD04
Watch Now